Modulation of influenza A virus replication by microRNA-9 through targeting MCPIP1

Journal of Medical Virology

Volumn 89, Issue 1, 2017, Pages 41-48

  Dong, Chunyan ^a   Sun, Xiaoning ^a   Guan, Zhenhong ^a   Zhang, Maolin ^a   Duan, Ming ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

influenza virus; MCPIP1; miR 9; replication

Indexed keywords

MATRIX PROTEIN; MICRORNA 9; NUCLEOPROTEIN; PROTEIN MCPIP1; RIBONUCLEASE; UNCLASSIFIED DRUG; VIRUS RNA; MICRORNA; MIRN92 MICRORNA, HUMAN; TRANSCRIPTION FACTOR; ZC3H12A PROTEIN, HUMAN;

A549 CELL LINE; ANIMAL CELL; ARTICLE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLUENZA A; INFLUENZA A VIRUS; LIFE CYCLE; NONHUMAN; PROGENY; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN TARGETING; REGULATORY MECHANISM; RNA DEGRADATION; VIRUS REPLICATION; ANTAGONISTS AND INHIBITORS; CELL LINE; EPITHELIUM CELL; IMMUNE EVASION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; VIROLOGY;

CELL LINE; EPITHELIAL CELLS; HUMANS; IMMUNE EVASION; INFLUENZA A VIRUS; MICRORNAS; RIBONUCLEASES; TRANSCRIPTION FACTORS; VIRUS REPLICATION;

EID: 84977561430     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24604     Document Type: Article

References (30)

1. Bakre A, Andersen LE, Meliopoulos V, Coleman K, Yan X, Brooks P, Crabtree J, Tompkins SM, Tripp RA. 2013. Identification of host kinase genes required for influenza virus replication and the regulatory role of microRNAs. PLoS ONE 8:e66796.
2. Bazzoni F, Rossato M, Fabbri M, Gaudiosi D, Mirolo M, Mori L, Tamassia N, Mantovani A, Cassatella MA, Locati M. 2009. Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc Natl Acad Sci USA 106:5282–5287.
3. Bhanja Chowdhury J, Shrivastava S, Steele R, Di Bisceglie AM, Ray R, Ray RB. 2012. Hepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A. J Virol 86:10221–10225.
4. Djuranovic S, Nahvi A, Green R. 2012. MiRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science 336:237–240.
5. Elena SF, Sole RV, Sardanyes J. 2010. Simple genomes, complex interactions: Epistasis in RNA virus. Chaos 20:026106.
6. Gao S, Song L, Li J, Zhang Z, Peng H, Jiang W, Wang Q, Kang T, Chen S, Huang W. 2012. Influenza A virus-encoded NS1 virulence factor protein inhibits innate immune response by targeting IKK. Cell Microbiol 14:1849–1866.
7. Klimov A, Balish A, Veguilla V, Sun H, Schiffer J, Lu X, Katz JM, Hancock K. 2012. Influenza virus titration, antigenic characterization, and serological methods for antibody detection. Methods Mol Biol 865:25–51.
8. Kumar N, Xin ZT, Liang Y, Ly H, Liang Y. 2008. NF-kappaB signaling differentially regulates influenza virus RNA synthesis. J Virol 82:9880–9889.
9. Lai FW, Stephenson KB, Mahony J, Lichty BD. 2014. Human coronavirus OC43 nucleocapsid protein binds microRNA 9 and potentiates NF-kappaB activation. J Virol 88:54–65.
10. Liang J, Saad Y, Lei T, Wang J, Qi D, Yang Q, Kolattukudy PE, Fu M. 2010. MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-kappaB signaling. J Exp Med 207:2959–2973.
11. Liang J, Song W, Tromp G, Kolattukudy PE, Fu M. 2008a. Genome-wide survey and expression profiling of CCCH-zinc finger family reveals a functional module in macrophage activation. PLoS ONE 3:e2880.
12. Liang J, Wang J, Azfer A, Song W, Tromp G, Kolattukudy PE, Fu M. 2008b. A novel CCCH-zinc finger protein family regulates proinflammatory activation of macrophages. J Biol Chem 283:6337–6346.
13. Lin RJ, Chien HL, Lin SY, Chang BL, Yu HP, Tang WC, Lin YL. 2013. MCPIP1 ribonuclease exhibits broad-spectrum antiviral effects through viral RNA binding and degradation. Nucleic Acids Res 41:3314–3326.
14. Lin RJ, Chu JS, Chien HL, Tseng CH, Ko PC, Mei YY, Tang WC, Kao YT, Cheng HY, Liang YC, Lin SY. 2014. MCPIP1 suppresses hepatitis C virus replication and negatively regulates virus-induced proinflammatory cytokine responses. J Immunol 193:4159–4168.
15. Liu S, Qiu C, Miao R, Zhou J, Lee A, Liu B, Lester SN, Fu W, Zhu L, Zhang L, Xu J, Fan D, Li K, Fu M, Wang T. 2013. MCPIP1 restricts HIV infection and is rapidly degraded in activated CD4+ T cells. Proc Natl Acad Sci USA 110:19083–19088.
16. Makki MS, Haseeb A, Haqqi TM. 2015. MicroRNA-9 promotes IL-6 expression by inhibiting MCPIP1 expression in IL-1beta-stimulated human chondrocytes. Arthritis Rheumatol 67:2117–2128.
17. Matsushita K, Takeuchi O, Standley DM, Kumagai Y, Kawagoe T, Miyake T, Satoh T, Kato H, Tsujimura T, Nakamura H, Akira S. 2009. Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay. Nature 458:1185–1190.
18. Mizgalska D, Wegrzyn P, Murzyn K, Kasza A, Koj A, Jura J, Jarzab B, Jura J. 2009. Interleukin-1-inducible MCPIP protein has structural and functional properties of RNase and participates in degradation of IL-1beta mRNA. FEBS J 276:7386–7399.
19. Niu J, Azfer A, Zhelyabovska O, Fatma S, Kolattukudy PE. 2008. Monocyte chemotactic protein (MCP)-1 promotes angiogenesis via a novel transcription factor, MCP-1-induced protein (MCPIP). J Biol Chem 283:14542–14551.
20. Ruckle A, Haasbach E, Julkunen I, Planz O, Ehrhardt C, Ludwig S. 2012. The NS1 protein of influenza A virus blocks RIG-I-mediated activation of the noncanonical NF-kappaB pathway and p52/RelB-dependent gene expression in lung epithelial cells. J Virol 86:10211–10217.
21. Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2004. Mapping the antigenic and genetic evolution of influenza virus. Science 305:371–376.
22. Suzuki HI, Arase M, Matsuyama H, Choi YL, Ueno T, Mano H, Sugimoto K, Miyazono K. 2011. MCPIP1 ribonuclease antagonizes dicer and terminates microRNA biogenesis through precursor microRNA degradation. Mol Cell 44:424–436.
23. Taubenberger JK, Morens DM. 2008. The pathology of influenza virus infections. Annual review of pathology. Ann Rev Pathol 3:499–522.
24. Terrier O, Textoris J, Carron C, Marcel V, Bourdon JC, Rosa-Calatrava M. 2013. Host microRNA molecular signatures associated with human H1N1 and H3N2 influenza A viruses reveal an unanticipated antiviral activity for miR-146a. J Gen Virol 94:985–995.
25. Varga ZT, Ramos I, Hai R, Schmolke M, Garcia-Sastre A, Fernandez-Sesma A, Palese P. 2011. The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS Pathog 7:e1002067.
26. Watanabe Y, Ibrahim MS, Suzuki Y, Ikuta K. 2012. The changing nature of avian influenza A virus (H5N1). Trends Microbiol 20:11–20.
27. Wu S, He L, Li Y, Wang T, Feng L, Jiang L, Zhang P, Huang X. 2013. MiR-146a facilitates replication of dengue virus by dampening interferon induction by targeting TRAF6. J Infect 67:329–341.
28. Yang L, Chao J, Kook YH, Gao Y, Yao H, Buch SJ. 2013. Involvement of miR-9/MCPIP1 axis in PDGF-BB-mediated neurogenesis in neuronal progenitor cells. Cell Death Dis 4:e960.
29. Yao H, Ma R, Yang L, Hu G, Chen X, Duan M, Kook Y, Niu F, Liao K, Fu M, Hu G, Kolattukudy P, Buch S. 2014. MiR-9 promotes microglial activation by targeting MCPIP1. Nat Commun 5:4386.
30. Zhou L, Azfer A, Niu J, Graham S, Choudhury M, Adamski FM, Younce C, Binkley PF, Kolattukudy PE. 2006. Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction. Circ Res 98:1177–1185.